Lunch Symposium 11: The advance of IO-based therapy in GU cancers
2020-08-235. Room 402C
12:00 ~ 12:30How to choose the most appropriate IO-based therapeutic strategy in 1L treatment of RCC: IO+IO combination or IO+TKI?Sumanta Kumar Pal吳文正
12:30 ~ 12:50Optimize the benefit of IO+IO in 1L RCC treatment from clinical trial to real world practice蘇柏榮吳文正
12:50 ~ 13:00Panel discussionAll吳文正